SALVATORE, Teresa
 Distribuzione geografica
Continente #
EU - Europa 8.694
NA - Nord America 5.368
AS - Asia 3.488
SA - Sud America 504
Continente sconosciuto - Info sul continente non disponibili 173
AF - Africa 46
OC - Oceania 2
Totale 18.275
Nazione #
RU - Federazione Russa 5.431
US - Stati Uniti d'America 5.198
SG - Singapore 1.182
CN - Cina 903
IE - Irlanda 872
IT - Italia 698
HK - Hong Kong 538
BR - Brasile 409
VN - Vietnam 387
GB - Regno Unito 374
UA - Ucraina 363
DE - Germania 301
SE - Svezia 189
FR - Francia 136
FI - Finlandia 110
KR - Corea 110
IN - India 94
TR - Turchia 81
CA - Canada 76
GR - Grecia 69
JP - Giappone 49
MX - Messico 45
BD - Bangladesh 35
AR - Argentina 32
AT - Austria 28
NL - Olanda 25
IR - Iran 22
BE - Belgio 18
CO - Colombia 18
ES - Italia 18
PL - Polonia 15
ZA - Sudafrica 14
EC - Ecuador 13
ID - Indonesia 12
VE - Venezuela 10
CZ - Repubblica Ceca 8
IQ - Iraq 8
MA - Marocco 8
PE - Perù 8
PK - Pakistan 8
UZ - Uzbekistan 8
JM - Giamaica 7
SA - Arabia Saudita 7
TT - Trinidad e Tobago 7
CH - Svizzera 6
CR - Costa Rica 6
LT - Lituania 6
EG - Egitto 5
HN - Honduras 5
JO - Giordania 5
NP - Nepal 5
PH - Filippine 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
EE - Estonia 4
PY - Paraguay 4
AZ - Azerbaigian 3
BB - Barbados 3
CL - Cile 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
GP - Guadalupe 3
GT - Guatemala 3
IL - Israele 3
MY - Malesia 3
NG - Nigeria 3
NI - Nicaragua 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SV - El Salvador 3
UY - Uruguay 3
AL - Albania 2
BG - Bulgaria 2
CW - ???statistics.table.value.countryCode.CW??? 2
EU - Europa 2
GE - Georgia 2
KW - Kuwait 2
LB - Libano 2
PA - Panama 2
SI - Slovenia 2
TH - Thailandia 2
AN - Antille olandesi 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CY - Cipro 1
IS - Islanda 1
KE - Kenya 1
LC - Santa Lucia 1
LV - Lettonia 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
QA - Qatar 1
Totale 18.099
Città #
Moscow 1.936
Dublin 860
Jacksonville 545
San Jose 532
Hong Kong 527
Singapore 503
Santa Clara 481
Chandler 479
Ashburn 422
Council Bluffs 291
Princeton 129
Ho Chi Minh City 123
The Dalles 111
Beijing 109
Seoul 108
Dallas 104
Hefei 100
Milan 98
Medford 94
New York 92
Ann Arbor 88
Hanoi 87
Roxbury 82
Nanjing 71
Bengaluru 66
Naples 61
Boardman 57
San Mateo 54
Bremen 51
Los Angeles 51
Munich 51
Caserta 48
Jinan 45
Wilmington 45
São Paulo 40
Cambridge 39
Woodbridge 38
Des Moines 31
Da Nang 27
Haiphong 25
Rome 25
Frankfurt am Main 24
Nanchang 23
Miano 22
Montreal 22
Düsseldorf 21
Tianjin 20
Atlanta 19
Kunming 19
Brussels 18
Torre Del Greco 18
Houston 17
Orem 17
Mountain View 16
Zanjan 16
Shenyang 15
Toronto 15
Chicago 14
Memphis 14
Boston 13
Taiyuan 13
Tokyo 13
Vienna 13
Amsterdam 12
Brooklyn 12
Changsha 12
Helsinki 12
Norwalk 12
Salerno 12
Biên Hòa 11
Denver 11
Guangzhou 11
Lanzhou 11
Mexico City 11
Nuremberg 11
Warsaw 11
Johannesburg 10
Napoli 10
Rio de Janeiro 10
Stockholm 10
Washington 10
Andover 9
Avellino 9
Chennai 9
Falkenstein 9
Hải Dương 9
North Bergen 9
Taizhou 9
Aversa 8
Brasília 8
Dong Ket 8
Haikou 8
Shanghai 8
Tashkent 8
Campinas 7
Fairfield 7
Ningbo 7
Quảng Ngãi 7
Sacramento 7
Seattle 7
Totale 9.460
Nome #
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 245
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 229
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 210
What changed in the Italian internal medicine and geriatric wards during the lockdown 207
Lo squatting test nella valutazione della neuropatia diabetica 198
Acute effects of beta-endorphin on cardiovascular function in patients with mild to moderate chronic heart failure 194
Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonism. 191
Diagnosi e trattamento precoce della vasculopatia cerebrale cronica nel paziente diabetico 183
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 177
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 177
Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity 176
Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent 176
Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy 176
Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis 174
Decreased insulin clearance as a feature of essential hypertension 169
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 168
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 168
Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin 168
A double-blind controlled study on the effect of tolrestat on diabetic autonomic neuropathy 167
Beta-endorphin and islet hormone release in humans: evidence for interference with cAMP 166
ANORECTAL FUNCTION IN DIABETES MELLITUS 166
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 166
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 165
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 164
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 163
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 163
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 162
Chronic magnesium administration enhances oxidative glucose metabolism in thiazide treated hypertensive patients 162
ALTERATIONS OF RECTAL SENSITIVITY IN DIABETIC PATIENTS 162
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 161
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry 155
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 155
Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus 151
Dual effect of beta-endorphin on insulin secretion in man 149
LO “SQUATTING” TEST NELLA VALUTAZIONE DELLA NEUROPATIA AUTONOMICA DIABETICA 147
Adapting the GLP-1-signaling system to the treatment of type 2 diabetes 146
Physiological elevations of plasma beta-endorphin alter glucose metabolism in obese, but not normal-weight, subjects 145
Aumentata prevalenza di Diabete tipo-2 nelle famiglie di individui affetti da Diabete tipo-1 Studio di 5 anni condotto nella Regione Campania 144
HCC and molecular targeting therapies: Back to the future 142
Cardiovascular benefits from gliflozins: Effects on endothelial function 142
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 141
Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease 140
An unusual case of primary systemic amyloidosis 140
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 140
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial. 139
Does free fatty acid infusion impair insulin action also through an increase in oxidative stress? 139
[Obesity and myocardial infarction] 139
Effect of insulin on left ventricular function during dynamic exercise in overweight and obese subjects 138
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 136
Beta-endorphin infusion restores acute insulin responses to glucose in type-2 diabetes mellitus 136
Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study 135
Comment on: Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma 135
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 134
Very large abscesses of lower limbs by Nocardia farcinica requiring surgical management in patient with minimal change disease under chronic steroid treatment 134
Is the common presence of glucose intolerance in old age a reliable index for the subsequent occurrence of fasting hyperglycemia? 132
LA RIDUZIONE DELLA CLEARANCE METABOLICA DELL’INSULINA CONTRIBUISCE ALL’IPERINSULINEMIA DEL PAZIENTE CON IPERTENSIONE ESSENZIALE 132
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 131
The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people 130
Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologist 130
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 130
Low protein alimentation normalizes renal haemodynamic response to acute protein ingestion in type 1 diabetic children 129
Valutazione della secrezione esocrina pancreatica mediante Lauril e BT-PABA test nel diabete mellito 128
An unforseen type 1 diabetes does make a complex diagnosis 128
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 127
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 125
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 123
[Large mediastinal mass of heterotopic thyroid tissue: a case report and review of literature] 122
Cochlear dysfunction in type 2 diabetes: a complication independent of neuropathy and acute hyperglycemia 122
Metabolic clearance rate of insulin in offspring of patients with non-insulin-dependente diabetes (NIDDM). 122
Sensorimotor evaluation of ano-rectal complex in diabetes mellitus. 120
Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage 120
Progress in the oral treatment of type 2 diabetes: update on DPP-IV inhibitors. 119
Restoration of sensitivity to sulfonylurea after strict glycaemic control with insulin in non-obese type 2 diabetic subjects 118
Comparative efficacy study of atorvastatin vs. simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia 118
Metabolic modifications induced by a combined insulin-glucose intravenous infusion before and after a protein-supplemented fast in obese subjects 117
Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study 116
Sensitivity to beta-endorphin as a cause of human obesity 115
VALUTAZIONE DEI NUOVI CRITERI CLASSIFICATIVI DEL DIABETE MELLITO NELL’ETA’ AVANZATA 115
Fast extramedullary pleural spread in a new diagnosis of multiple myeloma 115
ETA’ E BARORIFLESSO: VALUTAZIONE DELLO SQUATTING TO STANDYNG TEST MEDIANTE FINAPRES 113
Detection of early sympathetic cardiovascular neuropathy by squatting test in NIDDM 111
Hyperinsulinemia in offspring of non-insulin-dependent diabetes mellitus patients: the role played by abnormal clearance of insulin 111
Evaluation of various lung physiopathology tests in subjects with chronic bronchitis before and after administration of salbutamol 111
[Non-insulin-dependent diabetes in young subjects] 111
The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia 111
UPPER DIGESTIVE TRACT INVOLVEMENT IN TYPE 2 (NON INSULIN DIPENDENT) DIABETES: PH-MANOMETRIC AND ENDOSCOPIC STUDY 110
Effects of insulin on left ventricular function during dynamic exercise in overweight and obese subjects 110
INFLUENZA DELLO SFORZO SULLA PaO2 IN SOGGETTI CON SINDROME RESTRITTIVA 110
ESISTE UNA NETTA SEPARAZIONE NELLA PATOGENESI DELL’IPERGLICEMIA TRA DIABETICI INSULINO-DIPENDENTI E DIABETICI NON-INSULINO DIPENDENTI? 110
The impact of new onset diabetes on cardiovascular risks in orthotopic liver transplant recipients: findings from the COLT study 109
VALUTAZIONE DELLA SECREZIONE ESOCRINA PANCREATICA MEDIANTE LAURIL E BT-PAVA TEST NEL DIABETE MELLITO 109
Heart failure and chronic kidney disease in a registry of internal medicine wards 109
Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact 109
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 109
Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: a randomized double-blind placebo-controlled crossover study 108
Tolrestat for mild diabetic neuropathy. A 52-week, randomized, placebo-controlled trial 108
CORRELATION BETWEEN NAILFOLD VIDEOCAPILLAROSCOPY PATTERNS, LEFT VENTRICLE DYSFUNCTION AND PULMONARY DISEASE IN SYSTEMIC SCLEROSIS, 108
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 107
Increased VEGF Expression but Impaired VEGF Receptor Signaling In The Myocardium of Diabetic Type 2 Patients with Chronic Coronary Heart Disease 107
Liver cirrhosis in type II diabetic patients does not worsen insulin resistance 107
Totale 14.137
Categoria #
all - tutte 64.125
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022790 0 0 0 34 301 13 10 22 25 55 104 226
2022/20231.770 150 63 30 156 160 140 5 102 849 26 35 54
2023/2024664 54 33 29 57 230 77 7 16 5 8 58 90
2024/20252.099 6 36 16 40 342 241 329 171 314 224 215 165
2025/20268.926 364 360 433 393 767 5.050 486 316 310 206 160 81
2026/20271.477 55 183 629 610 0 0 0 0 0 0 0 0
Totale 18.275